The NY Attorney General’s Office announced settlements with two pharmaceutical companies accused of violating the False Claims Act.  Dava Pharmaceuticals will pay $11 million to resolve allegations that it underpaid rebates owed under the Medicaid Prescription Drug Rebate Program by fraudulently classifying its drugs as non-innovator drugs.  KV Pharmaceutical company will pay $17 million for allegedly accepting Medicaid reimbursement for drugs which were deemed “less than effective” by the FDA, and thus were ineligible for reimbursement by federal healthcare programs.

Read the entire article, “N.Y: Pharmaceutical Companies Pay $28M For Medicaid Violations”